Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


13.11.2017

1 Am J Pathol
1 Ann Thorac Surg
2 BMC Cancer
2 Br J Cancer
3 Cancer
1 Clin Cancer Res
1 Dis Esophagus
1 Hum Pathol
2 Int J Radiat Oncol Biol Phys
2 J Clin Endocrinol Metab
1 J Laryngol Otol
2 J Oral Maxillofac Surg
4 Laryngoscope
13 Oral Oncol
2 Otolaryngol Head Neck Surg
3 PLoS One
3 Radiother Oncol
2 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. KRUPAR R, Hautmann MG, Pathak RR, Varier I, et al
    Immuno-metabolic determinants of chemoradiotherapy response and survival in head and neck squamous cell carcinoma.
    Am J Pathol. 2017 Oct 26. pii: S0002-9440(17)30383.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  2. STAMATIS G, Fechner S, Rocha M, Weinreich G, et al
    Resection of the Tracheobronchial Bifurcation With Complete Preservation of Lung Parenchyma.
    Ann Thorac Surg. 2017;104:1741-1747.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. JIN Y, Liu M, Cheng L, Chen L, et al
    Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report.
    BMC Cancer. 2017;17:735.
    PubMed     Text format     Abstract available

  4. DI L, Fu KI, Xie R, Wu X, et al
    A modified endoscopic submucosal dissection for a superficial hypopharyngeal cancer: a case report and technical discussion.
    BMC Cancer. 2017;17:712.
    PubMed     Text format     Abstract available


    Br J Cancer

  5. WERNER TA, Forster CM, Dizdar L, Verde PE, et al
    CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
    Br J Cancer. 2017 Nov 7. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  6. WEI F, Wu Y, Tang L, He Y, et al
    BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  7. GUPTA A, Sonis ST, Schneider EB, Villa A, et al
    Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31095.
    PubMed     Text format     Abstract available

  8. HOBAN CW, Beesley LJ, Bellile EL, Sun Y, et al
    Individualized outcome prognostication for patients with laryngeal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31087.
    PubMed     Text format     Abstract available

  9. PRINTZ C
    First person: Maura L. Gillison, MD, PhD: The researcher who found the link between the human papillomavirus and head and neck cancers continues to lead new discoveries in the field.
    Cancer. 2017;123:4307.
    PubMed     Text format    


    Clin Cancer Res

  10. LIU X, Kumar M, Yang L, Molkentine DP, et al
    BAP1 is a novel target in HPV negative head and neck cancer.
    Clin Cancer Res. 2017 Nov 7. pii: clincanres.1573.2017.
    PubMed     Text format     Abstract available


    Dis Esophagus

  11. VISSER E, van Rossum PSN, van Veer H, Al-Naimi K, et al
    A structured training program for minimally invasive esophagectomy for esophageal cancer- a Delphi consensus study in Europe.
    Dis Esophagus. 2017 Nov 7. doi: 10.1093.
    PubMed     Text format     Abstract available


    Hum Pathol

  12. NASRI E, Wiesen LB, Knapik JA, Fredenburg KM, et al
    Eps8 expression is significantly lower in p16+ head and neck squamous cell carcinomas (HNSCC) compared to p16- HNSCC.
    Hum Pathol. 2017 Oct 28. pii: S0046-8177(17)30390.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  13. ROUTMAN DM, Funk RK, Tangsriwong K, Lin A, et al
    Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional Review.
    Int J Radiat Oncol Biol Phys. 2017;99:938-946.
    PubMed     Text format     Abstract available

  14. LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
    Online Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  15. HE H, Li W, Liyanarachchi S, Wang Y, et al
    The role of NRG1 in the predisposition to papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2017 Nov 7. doi: 10.1210/jc.2017-01798.
    PubMed     Text format     Abstract available

  16. MAZZIOTTI G, Formenti AM, Frara S, Olivetti R, et al
    HIGH PREVALENCE OF RADIOLOGICAL VERTEBRAL FRACTURES IN WOMEN ON TSH-SUPPRESSIVE THERAPY FOR THYROID CARCINOMA.
    J Clin Endocrinol Metab. 2017 Nov 7. doi: 10.1210/jc.2017-01986.
    PubMed     Text format     Abstract available


    J Laryngol Otol

  17. MANSOUR J, Sagiv D, Alon E, Talmi Y, et al
    Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma.
    J Laryngol Otol. 2017 Nov 10:1-6. doi: 10.1017/S0022215117002250.
    PubMed     Text format     Abstract available


    J Oral Maxillofac Surg

  18. DE CASTRO DK, Ng ZY, Holzer PW, Waner M, et al
    One-Stage Supramaximal Full-Thickness Wedge Resection of Vascular Lip Anomalies.
    J Oral Maxillofac Surg. 2017;75:2449-2455.
    PubMed     Text format     Abstract available

  19. PALLIYALIL M, Anehosur V, Joshi A, Acharya S, et al
    Histological Assessment of the Carotid Sheath in Patients With Oral Squamous Cell Carcinoma.
    J Oral Maxillofac Surg. 2017;75:2465-2476.
    PubMed     Text format     Abstract available


    Laryngoscope

  20. L'ESPERANCE HE, Kallogjeri D, Yousaf S, Piccirillo JF, et al
    Prediction of mortality and morbidity in head and neck cancer patients 80 years of age and older undergoing surgery.
    Laryngoscope. 2017 Nov 6. doi: 10.1002/lary.26858.
    PubMed     Text format     Abstract available

  21. BADRAN KW, Heineman TE, Kuan EC, St John MA, et al
    Is multidisciplinary team care for head and neck cancer worth it?
    Laryngoscope. 2017 Nov 6. doi: 10.1002/lary.26919.
    PubMed     Text format    

  22. HUTCHESON KA, Barrow MP, Warneke CL, Wang Y, et al
    Cough strength and expiratory force in aspirating and nonaspirating postradiation head and neck cancer survivors.
    Laryngoscope. 2017 Nov 8. doi: 10.1002/lary.26986.
    PubMed     Text format     Abstract available

  23. PETERSEN JF, Stuiver MM, Timmermans AJ, Chen A, et al
    Development and external validation of a risk-prediction model to predict 5-year overall survival in advanced larynx cancer.
    Laryngoscope. 2017 Nov 8. doi: 10.1002/lary.26990.
    PubMed     Text format     Abstract available


    Oral Oncol

  24. PATINO MA, Ramirez RE, Perez CA, Feng L, et al
    The impact of intraoperative opioid use on survival after oral cancer surgery.
    Oral Oncol. 2017;74:1-7.
    PubMed     Text format     Abstract available

  25. SU TL, Chen AN, Leong CP, Huang YC, et al
    The effect of home-based program and outpatient physical therapy in patients with head and neck cancer: A randomized, controlled trial.
    Oral Oncol. 2017;74:130-134.
    PubMed     Text format     Abstract available

  26. PAPAKOSTAS P, Tsaousi G, Stavrou G, Rachovitsas D, et al
    Percutaneous endoscopic gastrostomy feeding of locally advanced oro-pharygo-laryngeal cancer patients: Blenderized or commercial food?
    Oral Oncol. 2017;74:135-141.
    PubMed     Text format     Abstract available

  27. BONOMO P, Desideri I, Loi M, Lo Russo M, et al
    Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
    Oral Oncol. 2017;74:142-147.
    PubMed     Text format     Abstract available

  28. TAO Y, Gross N, Liu Y, Zhang L, et al
    A high ratio of IL-12Rbeta2-positive tumor-infiltrating lymphocytes indicates favorable prognosis in laryngeal cancer.
    Oral Oncol. 2017;74:148-156.
    PubMed     Text format     Abstract available

  29. AJMANI GS, Nocon CC, Wang CH, Bhayani MK, et al
    Assessment of adjuvant therapy in resected head and neck cancer with high-risk features.
    Oral Oncol. 2017;74:15-20.
    PubMed     Text format     Abstract available

  30. DIRVEN R, Ebrahimi A, Moeckelmann N, Palme CE, et al
    Tumor thickness versus depth of invasion - Analysis of the 8th edition American Joint Committee on Cancer Staging for oral cancer.
    Oral Oncol. 2017;74:30-33.
    PubMed     Text format     Abstract available

  31. MI JL, Zhang B, Pan YF, Su YX, et al
    Chemotherapy regimens containing taxanes or fluorouracil in nasopharyngeal carcinoma: Which better?
    Oral Oncol. 2017;74:34-39.
    PubMed     Text format     Abstract available

  32. WARD MC, Shah C, Adelstein DJ, Geiger JL, et al
    Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer.
    Oral Oncol. 2017;74:49-55.
    PubMed     Text format     Abstract available

  33. SZTURZ P, Budikova M, Vermorken JB, Horova I, et al
    Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data.
    Oral Oncol. 2017;74:68-76.
    PubMed     Text format     Abstract available

  34. HAKANSSON K, Rasmussen JH, Rasmussen GB, Friborg J, et al
    A failure-type specific risk prediction tool for selection of head-and-neck cancer patients for experimental treatments.
    Oral Oncol. 2017;74:77-82.
    PubMed     Text format     Abstract available

  35. FADEN DL, Thomas S, Cantalupo PG, Agrawal N, et al
    Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.
    Oral Oncol. 2017;74:8-14.
    PubMed     Text format     Abstract available

  36. ECONOMOPOULOU P, Kotsantis I, Kyrodimos E, Lianidou ES, et al
    Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
    Oral Oncol. 2017;74:83-89.
    PubMed     Text format     Abstract available


    Otolaryngol Head Neck Surg

  37. CURRY J, Tassone P, Gill K, Tuluc M, et al
    Tumor Metabolism in the Microenvironment of Nodal Metastasis in Oral Squamous Cell Carcinoma.
    Otolaryngol Head Neck Surg. 2017;157:798-807.
    PubMed     Text format     Abstract available

  38. SARASWATHULA A, Chen M, Negoita S, Divi V, et al
    American Joint Committee on Cancer Eighth Edition Changes in Staging Criteria: Implications for Data Collection.
    Otolaryngol Head Neck Surg. 2017;157:748-749.
    PubMed     Text format     Abstract available


    PLoS One

  39. LUCAS-ROXBURGH R, Benschop J, Lockett B, van den Heever U, et al
    The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population.
    PLoS One. 2017;12:e0186424.
    PubMed     Text format     Abstract available

  40. ZHANG S, Hu F, Liang H, Liu Y, et al
    Association between a miRNA-146a polymorphism and susceptibility to head and neck squamous cell carcinoma in Chinese patients: A meta-analysis of 8 case-control studies.
    PLoS One. 2017;12:e0186609.
    PubMed     Text format     Abstract available

  41. KIM A, Ashman P, Ward-Peterson M, Lozano JM, et al
    Racial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013.
    PLoS One. 2017;12:e0183782.
    PubMed     Text format     Abstract available


    Radiother Oncol

  42. TAKAHASHI N, Umezawa R, Takanami K, Yamamoto T, et al
    Whole-body total lesion glycolysis is an independent predictor in patients with esophageal cancer treated with definitive chemoradiotherapy.
    Radiother Oncol. 2017 Nov 3. pii: S0167-8140(17)32659.
    PubMed     Text format     Abstract available

  43. CEREDA E, Cappello S, Colombo S, Klersy C, et al
    Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy.
    Radiother Oncol. 2017 Oct 27. pii: S0167-8140(17)32655.
    PubMed     Text format     Abstract available

  44. BOGOWICZ M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, et al
    Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models.
    Radiother Oncol. 2017 Nov 6. pii: S0167-8140(17)32663.
    PubMed     Text format     Abstract available


    Thyroid

  45. NAM SH, Roh JL, Gong G, Cho KJ, et al
    Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Thyroid. 2017 Nov 8. doi: 10.1089/thy.2017.0334.
    PubMed     Text format     Abstract available

  46. KUO EJ, Thi WJ, Zheng F, Zanocco K, et al
    Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension.
    Thyroid. 2017 Nov 7. doi: 10.1089/thy.2017.0457.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: